Description |
EYA transcriptional coactivator and phosphatase 2 |
tektin 5 |
Image |
|
No pdb structure |
Cellular Component |
|
|
Molecular Function |
|
|
Biological Process |
|
|
Pathways |
|
|
Drugs |
|
|
Diseases |
|
|
GWAS |
- Allergic disease (asthma, hay fever and/or eczema) (age of onset) ( 32603359)
- Allergic disease (asthma, hay fever and/or eczema) (multivariate analysis) ( 32603359)
- Allergic rhinitis ( 31361310)
- Asthma ( 32296059)
- Brain volume in infants (intracranial brain volume) ( 28763065)
- Coffee consumption ( 31046077)
- FEV1 ( 30804560)
- Heel bone mineral density ( 30598549 28869591)
- High light scatter reticulocyte count ( 32888494)
- High light scatter reticulocyte percentage of red cells ( 32888494)
- Lung function (FVC) ( 30061609 30804560)
- Non-del(5q) myelodysplastic syndromes ( 31738830)
- Peak expiratory flow ( 30804560)
- Reticulocyte count ( 32888494)
- Thiazide-induced adverse metabolic effects in hypertensive patients ( 23400010)
- Triglyceride levels ( 32203549 32154731)
- Triglyceride levels in current drinkers ( 30698716)
- Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) ( 30698716)
- Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) ( 30698716)
- Type 2 diabetes ( 30054458 30297969)
- Visceral adipose tissue/subcutaneous adipose tissue ratio ( 22589738)
- Waist-to-hip ratio adjusted for BMI ( 26426971)
- Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour) ( 28443625)
- Waist-to-hip ratio adjusted for BMI (age <50) ( 26426971)
- Waist-to-hip ratio adjusted for BMI (age >50) ( 26426971)
- Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction) ( 28448500)
- Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction) ( 28443625)
- Waist-to-hip ratio adjusted for BMI in active individuals ( 28448500)
- Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test) ( 26426971)
- Waist-to-hip ratio adjusted for body mass index ( 25673412 28448500)
|
- Cerebrospinal AB1-42 levels in normal cognition ( 29274321)
- Chronic obstructive pulmonary disease ( 30804561)
- Eating disorders ( 23568457)
- Lung adenocarcinoma ( 28604730)
- Lung function (FEV1/FVC) ( 26635082 30804560)
- Neonatal total 25-hydroxyvitamin D levels (maternal genetic effect) ( 32047095)
- Nickel levels ( 26025379)
- Normal facial asymmetry (angle of surface orientation score) ( 30631343)
- Peak expiratory flow ( 30804560)
- Resting heart rate ( 27798624)
|
Interacting Genes |
35 interacting genes:
AATK
BAG3
CATSPER1
CDK18
DMRTB1
DTX2
DUSP21
ENKD1
FAM214B
GNAI2
GNAZ
HGS
IQUB
LGALS4
MED25
PATZ1
PAX9
PIN1
POGZ
RBPMS
RFX2
ROR2
SIX1
SIX4
SNRPC
SPG21
SUOX
TEKT4
TEKT5
TFG
TLE5
TRAF4
TRAPPC6A
TSSK3
VPS37C
|
46 interacting genes:
AKAP8L
BAG4
C19orf54
C7orf31
CABP2
CSKMT
DTX2
EPHB6
EYA2
FNDC3B
FOXH1
FOXI1
HGS
HOXA1
HOXB6
KLHL38
KRTAP12-4
KRTAP15-1
KRTAP19-6
KRTAP19-7
KRTAP6-2
LASP1
MAPKBP1
MGAT5B
NFKBID
NHLRC2
PITX1
PLSCR4
PROP1
PSMB4
QRICH1
RBPMS
RORB
RUNX1
SMARCB1
SMUG1
SPAG8
SSC4D
TBX15
TLX3
TNS2
TOX2
USP54
VENTX
ZMYND12
ZNF76
|
Entrez ID |
2139 |
146279 |
HPRD ID |
09041 |
08736 |
Ensembl ID |
ENSG00000064655
|
ENSG00000153060
|
Uniprot IDs |
E7ETN2
O00167
|
Q96M29
|
PDB IDs |
3GEB
3HB0
3HB1
4EGC
5ZMA
|
|
Enriched GO Terms of Interacting Partners? |
|
|
Tagcloud ? |
|
|
Tagcloud (Difference) ? |
|
|
Tagcloud (Intersection) ? |
|